Transplant Trials Development Lead
I am the Transplant Trials Development Lead, based in the Oxford Transplant Centre at the Churchill Hospital. My role involves overseeing clinical research governance and regulatory aspects for the three COPE trials. I am also involved in the development of new research proposals in organ transplantation with the aim of increasing the research portfolio of the Transplant Centre. The COPE trials consist of a liver study investigating Normothermic Machine Perfusion (NMP) vs Static Cold Storage (SCS), a kidney trial comparing Oxygenated Hypothermic Machine Perfusion Reconditioning after cold storage vs SCS alone and a kidney trial looking at HMP with the addition of oxygen vs HMP without oxygen.
I have worked in clinical trials since 1995 where I began as a Data Manager for the Clinical Trials Service Unit (CTSU). I have worked on many trials since in both primary and secondary care across a wide range of disease areas including cancer, crohn’s disease, heart disease, leukaemia and surgery. I previously worked within the Nuffield Department of Surgical Sciences on the ACST-2 trial and have been in my current role since March 2014.
Status update and interim results from the asymptomatic carotid surgery trial-2 (ACST-2).
ACST-2 Collaborative Group None. et al, (2013), Eur J Vasc Endovasc Surg, 46, 510 - 518
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group None. et al, (2010), Lancet, 376, 1658 - 1669